Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale

European Journal of Neurology

Volumn 22, Issue 1, 2015, Pages 37-43

  Martinez Martin, P ^a   Chaudhuri, K R ^b   Rojo Abuin, J M ^c   Rodriguez Blazquez, C ^a   Alvarez Sanchez, M ^d   Arakaki, T ^e   Bergareche Yarza, A ^f   Chade, A ^g   Garretto, N ^e   Gershanik, O ^g   Kurtis, M M ^h   Martinez Castrillo, J C ⁱ   Mendoza Rodriguez, A ^j   Moore, H P ^k   Rodriguez Violante, M ^l   Singer, C ^k   Tilley, B C ^m   Huang, J ^m   Stebbins, G T ⁿ   Goetz, C G ⁿ  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CSIC   (Spain)

^d CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^e HOSPITAL RAMOS MEJÍA   (Argentina)

^f HOSPITAL DONOSTIA   (Spain)

^g FAVALORO UNIVERSITY   (Argentina)

^h HOSPITAL RUBER INTERNACIONAL   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j Hospital Complejo Asistencial de Segovia   (Spain)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^m UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

MDS UPDRS; Non motor symptoms; Non motor symptoms scale; Parkinson's disease; Rating scales

Indexed keywords

AGED; ANXIETY DISORDER; APATHY; ARTICLE; COGNITIVE DEFECT; CONSTIPATION; CONVERGENT VALIDITY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DIZZINESS; ETHICS; FATIGUE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MOTOR DYSFUNCTION ASSESSMENT; NEUROLOGIC EXAMINATION; NONMOTOR SYMPTOM; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SLEEP DISORDER; SYMPTOM; UNIFIED PARKINSON DISEASE RATING SCALE; ADULT; DAILY LIFE ACTIVITY; DEVICES; MIDDLE AGED; PSYCHOMETRY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX;

EID: 84923071706     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12165     Document Type: Article

References (25)

1. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009; 373: 2055-2066.
2. Chaudhuri KR, Healy D, Schapira AHV. The non-motor symptoms of Parkinson's disease. Diagnosis and management. Lancet Neurol 2006; 5: 235-245.
3. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008; 23: 1428-1434.
4. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
5. Qin Z, Zhang L, Sun F, et al. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009; 15: 767-771.
6. Li H, Zhang M, Chen L, et al. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease. Mov Disord 2010; 25: 2740-2746.
7. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Ray Chaudhuri K, on behalf of the NMSS Validation Group. The impact of non motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011; 26: 399-406.
8. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting: study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-1629.
9. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-197.
10. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 697-701.
11. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005; 5: 275-283.
12. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
13. Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinson's disease. Mov Disord 2012; 27: 54-60.
14. Chaudhuri KR, Schapira AHV. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
15. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011; 26(Suppl 3): 42-80.
16. SCOPA scales. http://www.scopa-propark.eu/ (accessed 28 June 2012).
17. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-923.
18. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007; 22: 1901-1911.
19. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease. Neurology 2009; 73: 1584-1591.
20. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170.
21. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS part I for nonmotor symptoms in Parkinson's disease. Mov Disord 2012; 27: 79-83.
22. Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol 2013; 260: 228-236.
23. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
24. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005; 76: 58-63.
25. Verbaan D, van Rooden SM, Benit CP, van Zwet EW, Marinus J, van Hilten JJ. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 632-634.